Open access · CC-BY
via OpenAlex
Inflammation as a central mechanism in Alzheimer's disease
Jefferson W. Kinney, Shane M. Bemiller, Andrew S. Murtishaw, Amanda M. Leisgang Osse, Arnold Salazar, Bruce T. Lamb
Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · ▲ 2,243 citations
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder. In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD. Additional information on microglia signaling and a number of cytokines in AD are also reviewed. We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.trci.2018.06.014
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Kinney, J.W., Bemiller, S.M., Murtishaw, A.S., Osse, A.M.L., Salazar, A., & Lamb, B.T. (2018). Inflammation as a central mechanism in Alzheimer's disease. <em>Alzheimer s & Dementia Translational Research & Clinical Interventions</em>. https://doi.org/10.1016/j.trci.2018.06.014
Vancouver
Kinney JW, Bemiller SM, Murtishaw AS, Osse AML, Salazar A, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2018. doi:10.1016/j.trci.2018.06.014.
BibTeX
@article{jefferson2018Inflam,
title = {Inflammation as a central mechanism in Alzheimer's disease},
author = {Jefferson W. Kinney and Shane M. Bemiller and Andrew S. Murtishaw and Amanda M. Leisgang Osse and Arnold Salazar and Bruce T. Lamb},
journal = {Alzheimer s & Dementia Translational Research & Clinical Interventions},
year = {2018},
doi = {10.1016/j.trci.2018.06.014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neurochemistry 2007
Open access · OA
GABAAreceptors in aging and Alzheimer’s disease
ACS Chemical Neuroscience 2014
Citation only
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
BMB Reports 2020
Open access · CC-BY
Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
Journal of Alzheimer s Disease 2018
Open access · CC-BY
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Drug Design Development and Therapy 2018
Open access · CC-BY
Mechanism involved in insulin resistance via accumulation of &beta;-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer&rsquo;s disease
International Journal of Environmental Research and Public Health 2018
Open access · CC-BY